MRK is trading at $119.47, up 4.16%.
🟢 Merck & Company Inc is trading 4.16% up
Merck & Company Inc
Related News
MRK
Merck Tulisokibart Hits Phase 3 Goal, First-in-Class Success for Ulcerative Colitis
MRK
🔴 Merck & Company Inc is trading 3.1% down today despite expanded CAPVAXIVE FDA approval
MRK
Merck Expands CAPVAXIVE FDA Approval to High-Risk Children and Teens
MRK
Merck Shares Fall 3%, Medicare Rule Targets Keytruda Patent Loophole
MRK